title: Gender, hyperlipidemia, and coronary artery disease.
abstract: The importance of statins for the prevention and treatment of coronary artery disease (CAD), the recent paradoxical effects of hormone replacement therapy on prevention of CAD, and the role of nontraditional risk factors in CAD in women are examined.
authors.affiliation: Cleveland Clinic Foundation, Department of Medical Student Education, Ohio State University, Cleveland, Ohio, USA.
authors.forename: Dale R
authors.initials: DR
authors.lastname: Shepard
authors.forename: Hani
authors.initials: H
authors.lastname: Jneid
authors.forename: Holly L
authors.initials: HL
authors.lastname: Thacker
mesh_terms: D000328:Adult; D000368:Aged; D002316:Cardiotonic Agents / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control*; D015914:Estrogen Replacement Therapy; D005260:Female; D015438:Health Behavior; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy*; D008019:Life Style; D008297:Male; D008875:Middle Aged; D011322:Primary Prevention / Q000379:methods; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D012737:Sex Factors
chemical_list: D002316:Cardiotonic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride